SWOT Analysis for JFL Life Sciences Ltd.

Strong Performer, Under Radar Stocks (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge

Stocks in downtrend most likely to cross below SMA-200 soon
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Declining profits every quarter for the past 2 quarters
Increasing Trend in Non-Core Income
Top Losers
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Stocks Underperforming their Industry Price Change in the Quarter

High Delivery Percentage
Bullish or Bearish Candlestick Strength - Indices
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)

JFL Life Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats